NASDAQ · Healthcare · Biotechnology
Traws Pharma, Inc.
TRAW
Traws Pharma, Inc. CEO Iain D. Dukes · Market cap $13.6M.
$1.65
-0.03 · -1.79%
52w hi $3.2752w lo $0.97
Off 52w high 63.0%
72
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
—
Avg PT $8.00
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 16 | ORBIMED ADVISORS LLC | Buy | 597,729 | $1.67 | +$998K | 72 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay